N-(4,5-dimethylisoxazol-3-yl)-N-(methoxymethyl)-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzenesulfonamide
Intermediate
IntermediateConfidentiality：Public
- INN / Generic Name
- N-(4,5-dimethylisoxazol-3-yl)-N-(methoxymethyl)-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzenesulfonamide
- CAS No.
- 415697-56-2
- Current Status
- Official intermediate catalog (API: Sparsentan)
- MOQ
- On request
- Lead Time
- On request
- Price Range
- On request
Formulation & registration fields (API/FDF oriented — tap to expand)
- Dosage Form
- —
- Strength
- —
- Therapy Area
- Pharmaceutical Intermediates
- Indication
- API: Sparsentan
- GMP Certification
- —
- CEP
- No
- DMF Type
- —
- Stability Data
- —
- BE Required
- Not required / waivable
- Registration Pathway
- FSO supply (non-registered substance)
HS Code
2933.591100 customs bills on file
Registrable Markets
Global
Process / Sequence / Exact Price
- Process Summary
- —Synthesis route auto-filled from in-house Pharmacodia route data — verify full steps on SciFinder / Google Patents.
- Exact Price